Article
Effects of NT5C2 Germline Variants on 6-Mecaptopurine Metabolism in Children With Acute Lymphoblastic Leukemia.
Clinical pharmacology and therapeutics - 1 Jun 2021
Jiang Chuang, Yang Wenjian, Moriyama Takaya, Liu Chengcheng, Smith Colton, Yang Wentao, Qian Maoxiang, Li Ziping, Tulstrup Morten, Schmiegelow Kjeld, Crews Kristine R, Zhang Hui, Pui Ching-Hon, Evans William, Relling Mary, Bhatia Smita, Yang Jun J
Abstract excerpt
6-mercaptopurine (6-MP) is widely used in the treatment of acute lymphoblastic leukemia (ALL), and its cytotoxicity is primarily mediated by thioguanine nucleotide (TGN) metabolites. A recent genomewide association study has identified germline polymorphisms (e.g., rs72846714) in the NT5C2 gene associated with 6-MP metabolism in patients with ALL. However, the full spectrum of genetic variation in NT5C2 is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
